Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5
datasets available to search
ShareScore release 0.7.1
Dataset results
5 results for “FluView”
FluView 2018 HHS Region 1 Outpatient Illness and Viral Surveillance Data - Epidemiological Week 40 (archived by MIDAS-ISG)
<p><strong>Other(s)</strong></p> <p>MIDAS Informatics Service Group</p> <p><strong>Rights holder(s)</strong></p> <p>Centers for Disease Control and Prevention</p> <p>Description from the FluView Interactive web application (from which this file was downloaded):</p> <p>Viral Surveillance — Data collection from both the U.S. World Health Organization (WHO) Collaborating Laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories began during the 1997-98 season. The volume of tested specimens has greatly increased during this time due to increased participation and increased testing. During the 1997-98 season 43 state public health laboratories participated in surveillance, and by the 2004-05 season all state public health laboratories were participating in surveillance. The addition of NREVSS data during the 1997-98 season roughly doubled the amount of virologic data reported each week. </p> <p>The number of specimens tested and % positive rate vary by region and season based on different testing practices including triaging of specimens by the reporting labs, therefore it is not appropriate to compare the magnitude of positivity rates or the number of positive specimens between regions or seasons. </p> <p>The U.S. WHO and NREVSS collaborating laboratories report the total number of respiratory specimens tested and the number positive for influenza types A and B each week to CDC. Most of the U.S. WHO collaborating laboratories also report the influenza A subtype (H1 or H3) of the viruses they have isolated, but the majority of NREVSS laboratories do not report the influenza A subtype. </p> <p>For more information on virologic surveillance please visit:http://www.cdc.gov/flu/weekly/overview.htm#Viral</p> <p>Outpatient Illness Surveillance — Information on patient visits to health care providers for influenza-like illness is collected through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet). This collaborative effort between CDC, state and local health departments, and health care providers started during the 1997-98 influenza season when approximately 250 providers were enrolled. Enrollment in the system has increased over time and there were >3,000 providers enrolled during the 2010-11 season.</p> <p>The number and percent of patients presenting with ILI each week will vary by region and season due to many factors, including having different provider type mixes (children present with higher rates of ILI than adults, and therefore regions with a higher percentage of pediatric practices will have higher numbers of cases). Therefore it is not appropriate to compare the magnitude of the percent of visits due to ILI between regions and seasons.</p> <p>Baseline levels are calculated both nationally and for each region. Percentages at or above the baseline level are considered to be elevated.</p> <p>For more information on ILI surveillance and baselines please visit:http://www.cdc.gov/flu/weekly/overview.htm#Outpatient</p>
FluView 2018 National Outpatient Illness and Viral Surveillance Data - Epidemiological Week 40 (archived by MIDAS-ISG)
<p><strong>Other(s)</strong></p> <p>MIDAS Informatics Service Group</p> <p><strong>Rights holder(s)</strong></p> <p>Centers for Disease Control and Prevention</p> <p>Description from the FluView Interactive web application (from which this file was downloaded):</p> <p>Viral Surveillance — Data collection from both the U.S. World Health Organization (WHO) Collaborating Laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories began during the 1997-98 season. The volume of tested specimens has greatly increased during this time due to increased participation and increased testing. During the 1997-98 season 43 state public health laboratories participated in surveillance, and by the 2004-05 season all state public health laboratories were participating in surveillance. The addition of NREVSS data during the 1997-98 season roughly doubled the amount of virologic data reported each week. </p> <p>The number of specimens tested and % positive rate vary by region and season based on different testing practices including triaging of specimens by the reporting labs, therefore it is not appropriate to compare the magnitude of positivity rates or the number of positive specimens between regions or seasons. </p> <p>The U.S. WHO and NREVSS collaborating laboratories report the total number of respiratory specimens tested and the number positive for influenza types A and B each week to CDC. Most of the U.S. WHO collaborating laboratories also report the influenza A subtype (H1 or H3) of the viruses they have isolated, but the majority of NREVSS laboratories do not report the influenza A subtype. </p> <p>For more information on virologic surveillance please visit:http://www.cdc.gov/flu/weekly/overview.htm#Viral</p> <p>Outpatient Illness Surveillance — Information on patient visits to health care providers for influenza-like illness is collected through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet). This collaborative effort between CDC, state and local health departments, and health care providers started during the 1997-98 influenza season when approximately 250 providers were enrolled. Enrollment in the system has increased over time and there were >3,000 providers enrolled during the 2010-11 season.</p> <p>The number and percent of patients presenting with ILI each week will vary by region and season due to many factors, including having different provider type mixes (children present with higher rates of ILI than adults, and therefore regions with a higher percentage of pediatric practices will have higher numbers of cases). Therefore it is not appropriate to compare the magnitude of the percent of visits due to ILI between regions and seasons.</p> <p>Baseline levels are calculated both nationally and for each region. Percentages at or above the baseline level are considered to be elevated.</p> <p>For more information on ILI surveillance and baselines please visit:http://www.cdc.gov/flu/weekly/overview.htm#Outpatient</p>
FluView National, Regional, and State Level Outpatient Illness and Viral Surveillance 2017-2018 (archived by MIDAS-ISG)
<p>Description from the FluView Interactive web application (from which these files were downloaded):</p> <p>Viral Surveillance — Data collection from both the U.S. World Health Organization (WHO) Collaborating Laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories began during the 1997-98 season. The volume of tested specimens has greatly increased during this time due to increased participation and increased testing. During the 1997-98 season 43 state public health laboratories participated in surveillance, and by the 2004-05 season all state public health laboratories were participating in surveillance. The addition of NREVSS data during the 1997-98 season roughly doubled the amount of virologic data reported each week. </p> <p>The number of specimens tested and % positive rate vary by region and season based on different testing practices including triaging of specimens by the reporting labs, therefore it is not appropriate to compare the magnitude of positivity rates or the number of positive specimens between regions or seasons. </p> <p>The U.S. WHO and NREVSS collaborating laboratories report the total number of respiratory specimens tested and the number positive for influenza types A and B each week to CDC. Most of the U.S. WHO collaborating laboratories also report the influenza A subtype (H1 or H3) of the viruses they have isolated, but the majority of NREVSS laboratories do not report the influenza A subtype. </p> <p>For more information on virologic surveillance please visit:http://www.cdc.gov/flu/weekly/overview.htm#Viral</p> <p>Outpatient Illness Surveillance — Information on patient visits to health care providers for influenza-like illness is collected through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet). This collaborative effort between CDC, state and local health departments, and health care providers started during the 1997-98 influenza season when approximately 250 providers were enrolled. Enrollment in the system has increased over time and there were >3,000 providers enrolled during the 2010-11 season.</p> <p>The number and percent of patients presenting with ILI each week will vary by region and season due to many factors, including having different provider type mixes (children present with higher rates of ILI than adults, and therefore regions with a higher percentage of pediatric practices will have higher numbers of cases). Therefore it is not appropriate to compare the magnitude of the percent of visits due to ILI between regions and seasons.</p> <p>Baseline levels are calculated both nationally and for each region. Percentages at or above the baseline level are considered to be elevated.</p> <p>For more information on ILI surveillance and baselines please visit:http://www.cdc.gov/flu/weekly/overview.htm#Outpatient</p>
FluView National, Regional, and State Level Outpatient Illness and Viral Surveillance 2016-2017 (archived by MIDAS-ISG)
<p>Description from the FluView Interactive web application (from which these files were downloaded):</p> <p>Viral Surveillance — Data collection from both the U.S. World Health Organization (WHO) Collaborating Laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories began during the 1997-98 season. The volume of tested specimens has greatly increased during this time due to increased participation and increased testing. During the 1997-98 season 43 state public health laboratories participated in surveillance, and by the 2004-05 season all state public health laboratories were participating in surveillance. The addition of NREVSS data during the 1997-98 season roughly doubled the amount of virologic data reported each week. </p> <p>The number of specimens tested and % positive rate vary by region and season based on different testing practices including triaging of specimens by the reporting labs, therefore it is not appropriate to compare the magnitude of positivity rates or the number of positive specimens between regions or seasons. </p> <p>The U.S. WHO and NREVSS collaborating laboratories report the total number of respiratory specimens tested and the number positive for influenza types A and B each week to CDC. Most of the U.S. WHO collaborating laboratories also report the influenza A subtype (H1 or H3) of the viruses they have isolated, but the majority of NREVSS laboratories do not report the influenza A subtype. </p> <p>For more information on virologic surveillance please visit:http://www.cdc.gov/flu/weekly/overview.htm#Viral</p> <p>Outpatient Illness Surveillance — Information on patient visits to health care providers for influenza-like illness is collected through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet). This collaborative effort between CDC, state and local health departments, and health care providers started during the 1997-98 influenza season when approximately 250 providers were enrolled. Enrollment in the system has increased over time and there were >3,000 providers enrolled during the 2010-11 season.</p> <p>The number and percent of patients presenting with ILI each week will vary by region and season due to many factors, including having different provider type mixes (children present with higher rates of ILI than adults, and therefore regions with a higher percentage of pediatric practices will have higher numbers of cases). Therefore it is not appropriate to compare the magnitude of the percent of visits due to ILI between regions and seasons.</p> <p>Baseline levels are calculated both nationally and for each region. Percentages at or above the baseline level are considered to be elevated.</p> <p>For more information on ILI surveillance and baselines please visit:http://www.cdc.gov/flu/weekly/overview.htm#Outpatient</p>
FluView National, Regional, and State Level Outpatient Illness and Viral Surveillance 2015-2016 (archived by MIDAS-ISG)
<p>Description from the FluView Interactive web application (from which these files were downloaded):</p> <p>Viral Surveillance — Data collection from both the U.S. World Health Organization (WHO) Collaborating Laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories began during the 1997-98 season. The volume of tested specimens has greatly increased during this time due to increased participation and increased testing. During the 1997-98 season 43 state public health laboratories participated in surveillance, and by the 2004-05 season all state public health laboratories were participating in surveillance. The addition of NREVSS data during the 1997-98 season roughly doubled the amount of virologic data reported each week. </p> <p>The number of specimens tested and % positive rate vary by region and season based on different testing practices including triaging of specimens by the reporting labs, therefore it is not appropriate to compare the magnitude of positivity rates or the number of positive specimens between regions or seasons. </p> <p>The U.S. WHO and NREVSS collaborating laboratories report the total number of respiratory specimens tested and the number positive for influenza types A and B each week to CDC. Most of the U.S. WHO collaborating laboratories also report the influenza A subtype (H1 or H3) of the viruses they have isolated, but the majority of NREVSS laboratories do not report the influenza A subtype. </p> <p>For more information on virologic surveillance please visit:http://www.cdc.gov/flu/weekly/overview.htm#Viral</p> <p>Outpatient Illness Surveillance — Information on patient visits to health care providers for influenza-like illness is collected through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet). This collaborative effort between CDC, state and local health departments, and health care providers started during the 1997-98 influenza season when approximately 250 providers were enrolled. Enrollment in the system has increased over time and there were >3,000 providers enrolled during the 2010-11 season.</p> <p>The number and percent of patients presenting with ILI each week will vary by region and season due to many factors, including having different provider type mixes (children present with higher rates of ILI than adults, and therefore regions with a higher percentage of pediatric practices will have higher numbers of cases). Therefore it is not appropriate to compare the magnitude of the percent of visits due to ILI between regions and seasons.</p> <p>Baseline levels are calculated both nationally and for each region. Percentages at or above the baseline level are considered to be elevated.</p> <p>For more information on ILI surveillance and baselines please visit:http://www.cdc.gov/flu/weekly/overview.htm#Outpatient</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.